Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cassava Sciences Inc
(NQ:
SAVA
)
28.51
+0.12 (+0.42%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cassava Sciences Inc
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
32
33
Next >
SAVA Stock: The Social Media Chatter That Has Cassava Sciences Trending Today
December 21, 2021
Cassava Sciences (SAVA) stock is getting some extra attention today from traders on social media and we've got all the details.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 21, 2021
Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) stock moved upwards by 75.98% to $4.47 during Tuesday's pre-market session. The company's market cap stands at $62.8...
Via
Benzinga
26 Stocks Moving in Tuesday's Pre-Market Session
December 21, 2021
Gainers Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) rose 102% to $5.13 in pre-market trading after the company reported pan-coronavirus monoclonal antibody cocktail that retains...
Via
Benzinga
7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts
December 07, 2021
These seven drug stocks, a mix of growth, value, and moonshot plays, each stand to see big moves in the next twelve months.
Via
InvestorPlace
Exposures
COVID-19
Quick Take Technical Analysis: Cassava Sciences, Inc
November 30, 2021
Cassava Sciences, Inc (NASDAQ:SAVA) fell over 5% on Tuesda...
Via
Benzinga
65 Biggest Movers From Yesterday
December 21, 2021
Gainers Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index. Bluerock...
Via
Benzinga
2 Big Stock Bets That Are Insiders Are Buying Now
December 06, 2021
Reddit users picked their favorite biotech stocks, and all of them have fallen this year. The insiders have a different buying strategy.
Via
InvestorPlace
CORRECTING and REPLACING CASSAVA SCIENCES ALERT: Bragar Eagel & Squire, P.C. Is Investigating Cassava Sciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
December 04, 2021
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
CASSAVA SCIENCES ALERT: Bragar Eagel & Squire, P.C. Is Investigating Cassava Sciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
December 03, 2021
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
While Cassava Sciences Is a Risky Play, It Has Substantial Payoff Potential
December 03, 2021
Informed investors who can handle its high risk may want to take a look at speculative biotech play SAVA stock.
Via
InvestorPlace
Jim Cramer Weighs In On Carnival, Canadian Pacific Railway And More
December 02, 2021
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Fulgent Genetics, Inc. (NASDAQ:
Via
Benzinga
Should Investors Worry About the Federal Investigation of Cassava?
December 02, 2021
The investigation really isn't the underlying concern.
Via
The Motley Fool
Cassava Sciences Just Returned to the Buy Zone
November 22, 2021
There's no need to panic about SAVA stock, as Cassava Sciences just launched an important study focused on treating Alzheimer's disease.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
November 19, 2021
Gainers SCYNEXIS (NASDAQ:SCYX) stock rose 15.69% to $7.15 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 1.2 million shares...
Via
Benzinga
Cassava Sciences Kickstarts Second Late-Stage Alzheimer's Trial With Simufilam
November 18, 2021
Cassava Sciences Inc (NASDAQ: SAVA) has initiated a second Phase 3 study of simufilam in patients with Alzheimer's disease. The second Phase 3 study is...
Via
Benzinga
3 Biotech Stocks That Have More Than Tripled so far This Year
November 18, 2021
But can they keep up the momentum?
Via
The Motley Fool
61 Biggest Movers From Yesterday
November 18, 2021
Gainers Sono Group N.V. (NASDAQ: SEV) shares climbed 154.7% to close at $38.20 on Wednesday after the company priced its IPO at $15 per share. Braze, Inc. (NASDAQ: BRZE) jumped...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
2 More Stocks Set to 2x… 5x… 10x in 2022
November 17, 2021
Finding 10x stocks is possible; it's simply a matter of knowing what patterns to look for. Here are a couple of strong contenders.
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
Mid-Afternoon Market Update: Dow Falls 200 Points; Rockwell Medical Shares Spike Higher
November 17, 2021
Toward the end of trading Wednesday, the Dow traded down 0.58% to 35,930.89 while the NASDAQ fell 0.27% to 15,930.79. The S&P also fell, dropping 0.23% to 4,690.24. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
See Why Cassava Sciences Shares Are Falling On Wednesday?
November 17, 2021
The Wall Street Journal reported that the SEC had launched a probe into claims that Cassava Sciences Inc (NASDAQ: SAVA) manipulated data key to its case for...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Why Cassava Sciences Is Sliding Lower Today
November 17, 2021
Allegations of data manipulation that hammered the company -- and its stock price -- this summer won't be easily forgotten.
Via
The Motley Fool
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 17, 2021
Gainers EyePoint Pharmaceuticals (NASDAQ:EYP...
Via
Benzinga
Today’s Hot Penny Stocks: What’s Moving ZSAN, AVGR and CEI Higher Wednesday?
November 17, 2021
Today's hot penny stocks are catching the eyes of investors and we're diving into everything investors need to know about them on Wednesday!
Via
InvestorPlace
ROKU Stock Price Predictions: How Low One Analyst Thinks Roku Will Go
November 17, 2021
Roku (ROKU) stock price predictions aren't doing the shares any favors on Wednesday after one analyst put out a bearish take.
Via
InvestorPlace
Mid-Day Market Update: StoneCo Drops After Q3 Earnings; EyePoint Pharmaceuticals Shares Surge
November 17, 2021
Midway through trading Wednesday, the Dow traded down 0.51% to 35,958.22 while the NASDAQ rose 0.03% to 15,977.88. The S&P also fell, dropping 0.13% to 4,694.96. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
42 Stocks Moving In Wednesday's Mid-Day Session
November 17, 2021
Gainers Sono Group N.V. (NASDAQ: SEV) shares jumped 66% to $24.90 after the company priced its IPO at $15 per share. EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) shares climbed...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
SAVA Stock Alert: The SEC Investigation That Has Cassava Sciences Cratering Today
November 17, 2021
Cassava Sciences (SAVA) stock is on the move Wednesday as investors react to reports of an SEC investigation over possible data manipulation.
Via
InvestorPlace
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Cassava Sciences In Hot Water Again As Shorts Claim 'Extreme' Data Manipulation
November 17, 2021
In a filing, the short sellers claim the science backing Cassava's drug is impossible.
Via
Investor's Business Daily
Jim Cramer Likes This Stock Over Cassava Sciences And Biogen
November 17, 2021
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Cassava Sciences, Inc. (NASDAQ:
Via
Benzinga
Global Cancer Therapy Market Expected to Reach $268 Billion In 2026, With A CAGR Of 9.15%
November 16, 2021
Palm Beach, FL –November 16, 2021 – FinancialNewsMedia.com News Commentary – The COVID-19 pandemic has affected the healthcare systems globally and also has a significant impact on the cancer therapy...
Via
FinancialNewsMedia
Exposures
COVID-19
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.